X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (332) 332
Patent (32) 32
Publication (23) 23
Dissertation (11) 11
Paper (10) 10
Magazine Article (5) 5
Book / eBook (3) 3
Book Chapter (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Newspaper Article (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (85) 85
female (71) 71
middle aged (65) 65
index medicus (57) 57
male (57) 57
adult (53) 53
aged (53) 53
oncology (44) 44
physics (39) 39
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
chemotherapy (28) 28
antineoplastic combined chemotherapy protocols - adverse effects (21) 21
performing operations (21) 21
studies (21) 21
transporting (21) 21
treatment outcome (21) 21
research (20) 20
cisplatin (19) 19
mechanical metal-working without essentially removingmaterial (19) 19
punching metal (19) 19
working or processing of sheet metal or metal tubes, rods orprofiles without essentially removing material (19) 19
controlling (18) 18
mortality (18) 18
regulating (18) 18
control or regulating systems in general (17) 17
functional elements of such systems (17) 17
monitoring or testing arrangements for such systems orelements (17) 17
cancer (16) 16
analysis (15) 15
animals (15) 15
care and treatment (15) 15
13-cis retinoic acid (14) 14
13-cis-retinoic acid (14) 14
aged, 80 and over (14) 14
trial (14) 14
carcinoma (13) 13
critical care medicine (13) 13
measuring (13) 13
measuring angles (13) 13
measuring areas (13) 13
measuring irregularities of surfaces or contours (13) 13
measuring length, thickness or similar lineardimensions (13) 13
survival (13) 13
survival rate (13) 13
testing (13) 13
disease-free survival (12) 12
health aspects (12) 12
carboplatin (11) 11
interleukin-2 (11) 11
sepsis (11) 11
therapy (11) 11
cyclophosphamide (10) 10
experiment (10) 10
fluorouracil - administration & dosage (10) 10
neoplasm staging (10) 10
particle physics (10) 10
risk factors (10) 10
5-fluorouracil (9) 9
breast neoplasms - pathology (9) 9
follow-up studies (9) 9
high energy physics (9) 9
high energy physics - experiment (9) 9
ifosfamide (9) 9
life sciences (9) 9
maintenance therapy (9) 9
neoplasm metastasis (9) 9
pharmacology & pharmacy (9) 9
phase-ii (9) 9
physics - high energy physics - experiment (9) 9
pilot projects (9) 9
randomized-trial (9) 9
survival analysis (9) 9
breast cancer (8) 8
breast neoplasms - drug therapy (8) 8
carboplatin - administration & dosage (8) 8
combined modality therapy (8) 8
immunology (8) 8
immunotherapy (8) 8
interleukin-2 - therapeutic use (8) 8
isotretinoin - administration & dosage (8) 8
surgery (8) 8
tumors (8) 8
adjuvant chemotherapy (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
cardiac arrest (7) 7
cern lhc coll (7) 7
cisplatin - administration & dosage (7) 7
critically-ill patients (7) 7
deoxycytidine - analogs & derivatives (7) 7
dose-response relationship, drug (7) 7
drug administration schedule (7) 7
emergency medicine (7) 7
epidemiology (7) 7
experimental results (7) 7
hep (7) 7
ifosfamide - administration & dosage (7) 7
inflammation (7) 7
lung neoplasms - drug therapy (7) 7
medical research (7) 7
medicine & public health (7) 7
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (291) 291
Portuguese (78) 78
Spanish (25) 25
Italian (17) 17
French (12) 12
Chinese (5) 5
German (4) 4
Korean (2) 2
Russian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 3, pp. 514 - 523
BACKGROUND The objective of the current study was a retrospective evaluation of 100 consecutive premenopausal women with high‐risk, early breast carcinoma who... 
ovarian protection | adjuvant therapy | gonadotropin‐releasing hormone analogue | high‐risk early breast carcinoma | High-risk early breast carcinoma | Ovarian protection | Gonadotropin-releasing hormone analogue | Adjuvant therapy | AMENORRHEA | CYCLOPHOSPHAMIDE | TAMOXIFEN | METHOTREXATE | FLUOROURACIL | PREMENOPAUSAL PATIENTS | CANCER | gonadotropin-releasing hormone analogue | TRIAL | high-risk early breast carcinoma | THERAPY | ONCOLOGY | GOSERELIN | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Estrogen Receptor Modulators | Gonadotropin-Releasing Hormone - analogs & derivatives | Fluorouracil - administration & dosage | Infertility, Female - chemically induced | Adult | Female | Ovary - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Retrospective Studies | Chemotherapy, Adjuvant | Carcinoma - pathology | Carcinoma - drug therapy | Premenopause | Ovary - physiology | Treatment Outcome | Breast Neoplasms - drug therapy | Pregnancy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Age of Onset | Infertility, Female - prevention & control | Methotrexate - administration & dosage | Pregnancy Outcome | Care and treatment | Gonadotropin releasing hormone | Patient outcomes | Physiological aspects | Breast cancer | Research | Ovaries
Journal Article
International Journal of Oncology, ISSN 1019-6439, 03/2015, Volume 46, Issue 3, pp. 1354 - 1360
To prevent premature ovarian failure (POF), high-risk, premenopausal women with early breast cancer were given a luteinizing-hormone releasing hormone (LH-RH)... 
High-risk premenopausal early breast cancer | LH-RH analogues | Premature ovarian failure | Adjuvant therapy | ADJUVANT CHEMOTHERAPY | SURVIVAL | METAANALYSIS | HORMONE AGONISTS | adjuvant therapy | RISK | PREMENOPAUSAL WOMEN | premature ovarian failure | TRIAL | ONCOLOGY | high-risk premenopausal early breast cancer | RADIOTHERAPY | GOSERELIN | OVARIAN-FUNCTION
Journal Article
Medicina (Buenos Aires), ISSN 0025-7680, 08/2012, Volume 72, Issue 4, pp. 315 - 320
En carcinomas mamarios murinos (C4-HD) y en células de cáncer de mama humano (T47D) observamos que el progestágeno sintético, acetato de medroxiprogesterona... 
CCND1/MYC | ERa | Cáncer de mama | Breast cancer | REa | MPA
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 22, pp. 2117 - 2128
Journal Article
Medicina (Buenos Aires), ISSN 1669-9106, 08/2012, Volume 72, Issue 4, pp. 315 - 320
En carcinomas mamarios murinos (C4-HD) y en células de cáncer de mama humano (T47D) observamos que el progestágeno sintético, acetato de medroxiprogesterona... 
CCND1/MYC | Cáncer de mama | REa | MPA
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 4, pp. 323 - 334
Journal Article
Journal Article